share_log

Option Care Health Analyst Ratings

Option Care Health Analyst Ratings

期权护理健康分析师评级
Benzinga ·  2023/10/18 10:34
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/18/2023 33.78% JP Morgan $46 → $44 Maintains Overweight
07/28/2023 24.66% Barrington Research $34 → $41 Maintains Outperform
06/27/2023 18.58% Truist Securities → $39 Reiterates Buy → Buy
05/05/2023 3.37% Barrington Research $38 → $34 Maintains Outperform
05/05/2023 -1.19% Deutsche Bank $39 → $32.5 Maintains Buy
02/27/2023 15.54% Jefferies → $38 Reinstates → Buy
10/28/2022 15.54% Barrington Research $37 → $38 Maintains Outperform
08/22/2022 21.62% Goldman Sachs $31 → $40 Maintains Buy
07/28/2022 12.5% Barrington Research $33 → $37 Maintains Outperform
08/04/2021 -27.03% Canaccord Genuity $22 → $24 Maintains Buy
07/19/2021 -23.99% Goldman Sachs $20 → $25 Upgrades Neutral → Buy
03/12/2021 -27.03% Canaccord Genuity $20 → $24 Maintains Buy
01/22/2021 -33.11% Deutsche Bank → $22 Initiates Coverage On → Buy
01/11/2021 -36.15% JP Morgan → $21 Initiates Coverage On → Overweight
11/04/2020 -39.19% Canaccord Genuity $18 → $20 Maintains Buy
07/21/2020 -36.15% SunTrust Robinson Humphrey $18 → $21 Maintains Buy
06/24/2020 -45.27% B of A Securities → $18 Initiates Coverage On → Buy
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
10/18/2023 33.78% 摩根大通 $46→$44 维护 超重
07/28/2023 24.66% 巴灵顿研究公司 $34→$41 维护 跑赢大盘
2023年6月27日 18.58% Truist证券 →$39 重申 购买→购买
05/05/2023 3.37% 巴灵顿研究公司 $38→$34 维护 跑赢大盘
05/05/2023 -1.19% 德意志银行 $39→$32.5 维护
02/27/2023 15.54% 杰富瑞 →$38 恢复 →购买
10/28/2022 15.54% 巴灵顿研究公司 $37→$38 维护 跑赢大盘
2022/08/22 21.62% 高盛 $31→$40 维护
07/28/2022 12.5% 巴灵顿研究公司 $33→$37 维护 跑赢大盘
08/04/2021 -27.03% 卡纳科特·格纳奇 $22→$24 维护
07/19/2021 -23.99% 高盛 $20→$25 升级 中性→购买
03/12/2021 -27.03% 卡纳科特·格纳奇 $20→$24 维护
2021/01/22 -33.11% 德意志银行 →$22 开始承保 →购买
2021/11/01 -36.15% 摩根大通 →$21 开始承保 →超重
11/04/2020 -39.19% 卡纳科特·格纳奇 $18→$20 维护
07/21/2020 -36.15% SunTrust Robinson Humphrey $18→$21 维护
06/24/2020 -45.27% B of A证券 →$18 开始承保 →购买

What is the target price for Option Care Health (OPCH)?

OPCH的目标价格是多少?

The latest price target for Option Care Health (NASDAQ: OPCH) was reported by JP Morgan on October 18, 2023. The analyst firm set a price target for $44.00 expecting OPCH to rise to within 12 months (a possible 33.78% upside). 7 analyst firms have reported ratings in the last year.

摩根大通于2023年10月18日报道了Option Care Health(纳斯达克代码:OPCH)的最新目标价。这家分析公司将目标价定为44.00美元,预计OPCH将在12个月内上涨(可能上涨33.78%)。去年有7家分析公司公布了评级。

What is the most recent analyst rating for Option Care Health (OPCH)?

期权护理健康(OPCH)的最新分析师评级是多少?

The latest analyst rating for Option Care Health (NASDAQ: OPCH) was provided by JP Morgan, and Option Care Health maintained their overweight rating.

Option Care Health(纳斯达克股票代码:OPCH)的最新分析师评级由摩根大通提供,Option Care Health维持其增持评级。

When is the next analyst rating going to be posted or updated for Option Care Health (OPCH)?

OPCH(OPCH)的下一次分析师评级将于何时发布或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Option Care Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Option Care Health was filed on October 18, 2023 so you should expect the next rating to be made available sometime around October 18, 2024.

分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公共财务报表,与Option Care Health的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。Option Care Health的上一次评级是在2023年10月18日提交的,因此您应该预计下一次评级将在2024年10月18日左右提供。

Is the Analyst Rating Option Care Health (OPCH) correct?

分析师评级选项Care Health(OPCH)正确吗?

While ratings are subjective and will change, the latest Option Care Health (OPCH) rating was a maintained with a price target of $46.00 to $44.00. The current price Option Care Health (OPCH) is trading at is $32.89, which is out of the analyst's predicted range.

虽然评级是主观的,并将发生变化,但最新的选项护理健康(OPCH)评级保持不变,目标价在46.00美元至44.00美元之间。目前的价格期权Care Health(OPCH)的交易价格为32.89美元,超出了分析师的预测区间。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发